Frontiers in oncology · 2026
Case Report: FAPI PET/CT detected occult contralateral DCIS and supraclavicular metastasis, guiding neoadjuvant therapy in synchronous bilateral breast cancer.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cong Lin, Ji Bin, Gu Yiqi, Wu Yilin, Wang Wan
Аннотация
BACKGROUND: Accurate staging is critical for breast cancer management. While [18F]FDG PET/CT is the standard for metabolic imaging, it has limitations in detecting tumors with low glucose metabolism and small regional metastases. Fibroblast activation protein inhibitor (FAPI) PET/CT targets cancer-associated fibroblasts and offers a novel diagnostic avenue.
CASE PRESENTATION: A female patient presented with left-sided inflammatory breast cancer. Conventional [18F]FDG PET/CT showed uptake in the left breast but missed regional spread and contralateral disease. Conversely, a supplemental [18F]AlF-NOTA-FAPI-04 PET/CT revealed intense uptake in the left breast (SUVmax 19.45) and detected occult metastases in the left axillary (SUVmax 15.12) and supraclavicular lymph nodes (SUVmax 14.83). Crucially, it also identified a high-uptake lesion in the right breast (SUVmax 15.06), which biopsy confirmed as DCIS, upstaging the diagnosis to synchronous bilateral breast cancer. Following neoadjuvant chemotherapy, follow-up FAPI PET/CT demonstrated that uptake in the supraclavicular and axillary nodes dropped to background levels, predicting a complete response (CR). Postoperative pathology confirmed CR in the lymph nodes.
CONCLUSION: This case highlights the superior sensitivity of FAPI PET/CT over FDG PET/CT in detecting low-metabolic malignancies like DCIS and accurately staging regional nodal involvement (including supraclavicular nodes). FAPI PET/CT played a decisional role in upstaging the patient and monitoring neoadjuvant therapy response.
CASE PRESENTATION: A female patient presented with left-sided inflammatory breast cancer. Conventional [18F]FDG PET/CT showed uptake in the left breast but missed regional spread and contralateral disease. Conversely, a supplemental [18F]AlF-NOTA-FAPI-04 PET/CT revealed intense uptake in the left breast (SUVmax 19.45) and detected occult metastases in the left axillary (SUVmax 15.12) and supraclavicular lymph nodes (SUVmax 14.83). Crucially, it also identified a high-uptake lesion in the right breast (SUVmax 15.06), which biopsy confirmed as DCIS, upstaging the diagnosis to synchronous bilateral breast cancer. Following neoadjuvant chemotherapy, follow-up FAPI PET/CT demonstrated that uptake in the supraclavicular and axillary nodes dropped to background levels, predicting a complete response (CR). Postoperative pathology confirmed CR in the lymph nodes.
CONCLUSION: This case highlights the superior sensitivity of FAPI PET/CT over FDG PET/CT in detecting low-metabolic malignancies like DCIS and accurately staging regional nodal involvement (including supraclavicular nodes). FAPI PET/CT played a decisional role in upstaging the patient and monitoring neoadjuvant therapy response.